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Abstract
Background: Few studies of the prevalence of hepatitis C virus (HCV) infection have focussed
on women who work as street sex workers to finance their drug use.
Methods: The investigators report the survey findings of such a population in Glasgow. All
women attending the health and social care drop-in centre, situated in Glasgow's "Red Light
Area", during a four-week period in 1999 were invited to participate in a survey involving the
provision of a saliva sample for anonymous HCV testing and the self-completion of a
questionnaire seeking demographic, sexual and injecting practice data.
Results: Of the 223 women who attended, 51% agreed to participate. Of the 98 women who
provided a sufficient saliva sample, 64% (95% CI: 54%–74%) tested HCV antibody positive; 98%
of those who tested positive had ever injected drugs. Adjusting for the 85% sensitivity of the
saliva test, the HCV antibody prevalence among IDU sex workers sampled was 81%; a rate which
is considerably higher than those recorded, contemporaneously, among Glasgow IDUs generally.
Two factors were independently associated with HCV antibody positivity in saliva: ever shared
needles and syringes (adjusted OR 5.7, 95% CI 2–16) and number of times imprisoned (adjusted
OR 7.3, 95% CI 1.4–39, for more than five times compared to zero times).
Conclusion:  Women who engage in street sex work to finance their drug habit are a
particularly desperate, chaotic and vulnerable population. This study demonstrates that their
HCV infection risk may be greater than that for other IDUs. Those responsible for designing
interventions to prevent HCV infection among IDUs should consider the special needs of this
group.
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Background
Hepatitis C Virus (HCV) infection is one of the major pub-
lic health issues of the 21st Century. In the UK, it is esti-
mated that 200,000 to 450,000 individuals, mostly
persons who have injected drugs, are infected with HCV
[1,2]. Many studies of the prevalence and determinants of
HCV among injecting drug users (IDUs) have been under-
taken [3] but few have focussed on women who work as
street prostitutes to finance their drug habit [4]; previous
studies among female sex workers have generally involved
a low proportion (≤ 5%) of IDUs [5,6]. The investigators
report the survey findings of such a population in Glas-
gow, a city with one of the highest prevalences of injecting
drug use in Europe (2.7% of 20–29 year olds in 1990) [7].
Methods
Setting and Population
The study was conducted among street sex workers (i.e.
sex workers who solicited clients from the street) attend-
ing a health and social care drop-in centre (DIC) for sex
workers, established in 1988 in Glasgow's "Red Light
Area" [8]. The centre is open nightly, except Saturday,
from 7.30 pm until midnight and is managed jointly by
the Greater Glasgow Health Board and the Glasgow City
Council Social Work Department. It provides a social
environment where women can chat, have tea and sand-
wiches and use a wash-room. Social Work staff provide
information, advice and organisational support, and a
doctor and a nurse run a medical service which responds
to a wide range of conditions, particularly those relating
to drug-injecting. Condoms are freely available, as are
needles and syringes. One thousand and three different
street sex workers had attended the DIC between January
1995 and March 1999.
Design
All women attending the DIC during a four-week period
in 1999 were invited to participate in a survey involving
the provision of a saliva sample for anonymous HCV test-
ing and the self-completion (overseen by a researcher) of
a questionnaire seeking demographic, sexual and inject-
ing practice data.
Saliva testing of HCV antibodies
A modified ELISA assay (Monolisa anti-HCV-Sanofi Pas-
teur, France) [9] was used by the West of Scotland
Regional Virus Laboratory, Gartnavel General Hospital,
Glasgow, to detect HCV antibodies in saliva; the assay's
sensitivity and specificity were 85% and 100%, respec-
tively [9].
Data Analysis
All analyses were conducted using S-PLUS Software [10].
Univariate and multifactorial logistic regression analysis
was performed to determine the main predictors of an
HCV antibody test result in saliva; all factors significantly
associated with HCV antibody status at the 5% level in the
univariate analyses were considered in the multiple
regression analyses.
Results
Sample Characteristics
Two hundred and twenty three women attended the DIC
during the study period; 114 (51%) agreed to participate.
All non-participants gave their reasons for non-participa-
tion as "insufficient time" or "not interested". The mean
age of participants was 26 years (range 16–46); 19% (21/
111) were aged less than 21 years. The mean age of com-
mencement in street sex work was 21 years (range 10–36).
Respondents had worked as street sex workers for a mean
of 4.6 years (range 0–32; SD 5.9) and had been attending
the DIC for a mean of 3.5 years (range 0–12; SD 3.3). Sev-
enty-three per cent (81/111) had begun using the DIC in
the year they began street sex working.
Ninety-three per cent of women (99/107) had ever
injected drugs. Eighty four percent (96/114) of all
respondents and 93% (92/99) of those who had ever
injected reported that they were currently taking heroin.
Most IDUs had commenced injecting prior to, or in the
year they commenced street sex work.
Risk Behaviour
Of the 99 respondents who had ever injected drugs, 84%
(83/99) were current IDUs, injecting, on average, two to
three times daily. Ninety-seven per cent (100/103) and
90% (96/107) of women reported using condoms "all of
the time" when having straight and oral sex with their cli-
ents, respectively.
Hepatitis C Saliva Test Results
Saliva samples were obtained from 103 participants; 5%
of these proved insufficient for testing. Of the remaining
98, 63 (64.3%, 95% CI: 53.9%–73.5%) tested HCV anti-
body positive.
Ninety-eight per cent (61/62) of those who tested positive
had ever injected drugs; the injector status of one HCV
positive individual was not reported. Of those who pro-
vided a sufficient sample and had ever injected, 68.5%
(61/89) were HCV antibody positive in saliva. Among
non-injecting sex workers, the prevalence of HCV anti-
bodies was 14.3% (1/7).
Determinants of HCV antibody positivity in saliva (Table 
1)
At a univariate level, respondents who had been injecting
for more years were significantly more likely to be HCVHarm Reduction Journal 2008, 5:11 http://www.harmreductionjournal.com/content/5/1/11
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antibody positive; the prevalence of HCV antibodies in
the saliva of those who had injected for under two years
was 50%, while that for more than ten years was 92%.
Respondents who had ever received help for their drug
problem were also significantly more likely to test HCV
antibody positive in saliva (with a prevalence of 72%
compared to 44% among those who had never received
help for their drug problem). Respondents who had ever
shared needles were significantly more likely to be HCV
antibody positive in saliva (85% compared to 48%
among injectors who had never shared) and those who
had been incarcerated for more than five times were sig-
nificantly more likely to be HCV antibody positive in
saliva (91% compared to 49% among those who had
never been imprisoned).
In the multiple regression analysis, two factors were inde-
pendently associated with HCV antibody positivity in
saliva: i) ever shared needles and syringes (adjusted OR
5.7 (95% CI 2–16), compared to IDUs who reported
never having shared) and, ii) number of times imprisoned
(adjusted OR 7.3 (95% CI 1.4–39) for more than five
times, compared to zero times). After adjustment for these
two factors, other variables, including those significant at
a univariate level (i.e. time since onset of injecting or ever
received help for drug problems), were not significantly
associated with HCV antibody status and were excluded
from the final multiple regression model shown in Table
1.
Discussion
The sample was not necessarily representative of Glas-
gow's street sex workers due to potential participation bias
as a consequence of refusal to be studied, and selection
bias due to the approach of convenience sampling in a
health and social care setting for this population. Never-
theless, the finding that nearly three-quarters of respond-
ents had attended the DIC within one year of beginning
street sex work is consistent with a very high proportion of
Glasgow's city centre street-workers accessing this service;
further, the average number of women attending the DIC
during the 1990s was 500–1,000, a figure similar to the
Table 1: Logistic risk scores for hepatitis C antibody positive status in saliva (n = 98 female street sex-workers)
Determinant Total Hepatitis C antibodies in 
saliva
Odds Ratio (95% confidence interval)‡
N (%) n (% of N) Univariate Multifactorial
Study group 98 (100%) 63 (64%)
Age (years) (3 non-responses) 16–20 18 (19%) 7 (39%)
21–25 34 (36%) 21 (62%) 1.08 (0.99–1.17) NS
26–30 29 (31%) 25 (86%)
> 30 14 (15%) 9 (64%)
Time since began prostitution (years) 
(2 non-responses)
≤ 1 40 (42%) 23 (58%) 1.00 (Baseline)
2–5 32 (33%) 22 (69%) 1.63 (0.61–4.31) NS
> 5 24 (25%) 17 (71%) 1.80 (0.61–5.29)
Time since onset of injecting drug use 
(years) (2 non-responses)
Never injected 7 (7%) 1 (14%)
< 2 30 (31%) 15 (50%)
2–5 27 (28%) 18 (67%) 1.20 (1.06–1.35)* NS
6–10 19 (20%) 16 (84%)
> 10 13 (14%) 12 (92%)
Ever shared needles for injecting (4 
non-responses)
Yes 47 (50%) 40 (85%) 6.31 (2.31–17.29) 5.75 (2.01–16.46)
No 40 (43%) 19 (48%) 1.00 (Baseline) 1.00 (Baseline)
Never injected 7 (7%) 1 (14%) 0.18 (0.02–1.63) 0.26 (0.03–2.48)
Ever received help for drug problems 
(3 non-responses)
Yes 68 (72%) 49 (72%) 3.22 (1.28–8.13) NS
No 27 (28%) 12 (44%) 1.00 (Baseline)
Number of times in prison (16 non-
responses)
None 33 (40%) 16 (49%) 1.00 (Baseline) 1.00 (Baseline)
1–5 times 26 (32%) 14 (54%) 1.24 (0.44–3.47) 1.27 (0.39–4.14)
> 5 times 23 (28%) 21 (91%) 11.16 (2.26–55.16) 7.30 (1.35–39.46)
‡ Results in bold are statistically significant at the 5% level.
* Time since onset of injecting drug use was entered as a continuous variable in the regression analysis, where non-injectors were coded as missing 
values.
NS indicates not included in the multifactorial model, because of lack of significance.Harm Reduction Journal 2008, 5:11 http://www.harmreductionjournal.com/content/5/1/11
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estimated number of women working as street sex work-
ers in Glasgow at any one time [11].
Adjusting for the 85% sensitivity of the saliva test, the
HCV antibody prevalence among IDU sex workers was
81%, a rate which is considerably higher than those (60–
70%) recorded, contemporaneously, for Glasgow IDUs
generally [1,12]. Indeed, this prevalence is considerably
higher than any recorded among IDU populations
throughout the UK between 1991 and 2005 [13].
The HCV antibody prevalence of 50% among sex workers
who began to inject in the previous two years – between
1997 and 1999 – indicates that harm reduction interven-
tions, such as needle/syringe exchange and methadone
maintenance treatment – introduced in the late 1980s and
early 1990s – had not controlled the spread of HCV in this
population. This rate was significantly (χ2(1) = 10.3, p =
0.001) higher than that found in a community-wide sam-
ple of IDUs, recruited in Glasgow during 1999, who had
injected for under two years (20% in saliva, 27/136;
unpublished data, Health Protection Scotland). Despite
the provision of a wide range of services at the DIC,
including guidance about safe injecting, counselling and
needle and syringe provision, and that the DIC was
attended by a large proportion of participants within 12
months of their injecting and sex working debuts, the inci-
dence of HCV infection among this group remains high.
Research has shown that while harm reduction pro-
grammes (e.g. methadone maintenance treatment and
needle exchange programmes) have been effective in
reducing the incidence of HIV [14,15], they have been less
successful in reducing the incidence of HCV [16-19].
Some authors have suggested this may be the result of the
harm reduction effort focusing on needle and syringe
sharing [20] when the sharing of injecting paraphernalia
other than needles and syringes (e.g. spoons and filters)
has been demonstrated to increase HCV transmission [21-
23]. However, data on paraphernalia was not collected in
the current study.
The two principal determinants of HCV antibody positiv-
ity – ever sharing needles/syringes and frequency of
imprisonment – have been widely recognised among
IDUs [19,24,25], though, hitherto, not specifically in this
sub-group.
The high rate of HCV antibody positivity (48%) among
the IDUs who declared never sharing needles and syringes
is not an uncommon finding. Poor recall, mendacity and
the acquisition of HCV through, for example, the sharing
of other injecting equipment such as spoons and filters
[26] are possible reasons for this observation.
Since the women reported that they almost always used
condoms when engaging in sexual intercourse with their
clients and since the efficacy of HCV transmission through
such unprotected behaviour is known to be low, appreci-
able sexual transmission of infection between such sex
workers and their clients is unlikely to occur. HCV preva-
lence surveys of non-IDU sex workers, the numbers of
whom were considerably greater than that recruited in
this investigation, indicate rates of less than 1% [4,27-29].
Conclusion
This study examines the prevalence and determinants of
hepatitis C virus infection among female drug injecting
sex workers, an understudied and difficult to reach popu-
lation. Women who engage in street sex work to finance
their drug use are a particularly desperate, chaotic and vul-
nerable population. The HCV antibody prevalence among
IDU sex workers sampled was 81%. Therefore, this study
demonstrates that their HCV infection risk may be greater
than that for other IDUs. Furthermore, the majority of
those interviewed reported using condoms with clients
highlighting the effectiveness of the DIC in addressing
sexual risk taking behaviour among sex workers. There-
fore, it is unlikely that the increased prevalence is a result
of sexual transmission, rather the results demonstrate that
ever sharing needles and syringes and the frequency of
incarceration were associated with HCV antibody positiv-
ity. Thus, those responsible for designing interventions to
prevent HCV infection among IDUs should consider the
special needs of this group. Since 1999, a methadone
clinic has been operational at the DIC and a needle
exchange service established in hostels for homeless per-
sons – many of whom are IDU sex workers. It remains to
be seen how effective these additional initiatives have
been in stemming the spread of HCV among this popula-
tion.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
Avril Taylor conceived of the study, participated in its
design, project managed the study and drafted and criti-
cally revised the manuscript. Sharon Hutchinson per-
formed the statistical analysis, and drafted and critically
revised the manuscript. Gail Gilchrist participated in the
study design, collected data and samples, and drafted
early manuscript. Sheila Cameron conducted analysis of
saliva samples. Susan Carr conceived of the study, and
participated in its design. David Goldberg conceived of
the study, participated in its design and critically revised
the manuscript. All authors read and approved the final
manuscript.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Harm Reduction Journal 2008, 5:11 http://www.harmreductionjournal.com/content/5/1/11
Page 5 of 5
(page number not for citation purposes)
Acknowledgements
No external funding was received to conduct the study. We would like to 
thank the interviewers involved in this study, and the staff and participants 
from the health and social care drop-in centre for their support and 
involvement.
References
1. Hutchinson SJ, Roy KM, Wadd S, Bird SM, Taylor A, Anderson E,
Shaw L, Codere G, Goldberg DJ: Hepatitis C virus infection in
Scotland: epidemiological review and public health chal-
lenges.  Scott Med J 2006, 51:8-15.
2. Hepatitis C in England: The First Health Protection Agency Annual Report
2005 London: Health Protection Agency Centre for Infections; 2005. 
3. Hagan H, Des Jarlais DC: HIV and HCV infection among inject-
ing drug users.  Mt Sinai J Med 2000, 67:423-428.
4. Echevarria S, San Miguel G, Pelayo T, Salas C, Casafont F, Crespo F,
Pons Romero F: Risk for Hepatitis C virus (HCV) and human
immunodeficiency virus (HIV) infections among prostitutes.
Genitourin Med 1993, 69:321-325.
5. Mesquita PE, Granato CF, Castelo A: Risk factors associated with
hepatitis C virus (HCV) infection among prostitutes and
their clients in the city of Santos, Sao Paulo State, Brazil.  J
Med Virol 1997, 51:338-343.
6. McDonnell RJ, McDonnell PM, O'Neill M, Mulcahy F: Health risk
profile of prostitutes in Dublin.  Int J STD AIDS 1998, 9:485-488.
7. Frischer M, Leyland A, Cormack R, Goldberg D, Bloor M, Green ST,
Taylor A, Covell R, McKeganey N, Platt S: Estimating the popula-
tion prevalence of injection drug use and infection with
human immunodeficiency virus among injection drug users
in Glasgow.  Am J Epidemiol 1993, 138:170-181.
8. Gilchrist G, Taylor A, Goldberg D, Mackie C, Denovan A, Green ST:
Behavioural and Lifestyle Study of women using a Drop-in
Centre for female street sex workers in Glasgow, Scotland:
a 10-year comparative study.  Addict Res Theory 2001, 9:43-48.
9. Cameron SO, Wilson KS, Good T, McMenamin J, McCarron B, Pithie
A, Fox R: Detection of antibodies against Hepatitis C virus in
saliva: a marker of viral activity.  J Viral Hepat 1999, 6:141-144.
10. Data Analysis Products Division: S-PLUS 2000 Guide to Statistics Seat-
tle: MathSoft; 1999. 
11. McKeganey N, Barnard M, Leyland A, Coote I, Follet E: Female
streetworking prostitution and HIV infection in Glasgow.
BMJ 1992, 305:801-5.
12. Roy KM, Hutchinson SJ, Wadd S, Tayor A, Cameron SO, Burns S,
Molyneaux P, McIntyre PG, Goldberg DJ: Hepatitis C virus infec-
tion among injecting drug users in Scotland: a review of prev-
alence and incidence data and the methods used to generate
them.  Epidemiol Infect  in press.
13. Roy K, Hay G, Andraghetti R, Taylor A, Goldberg D, Wiessing L:
Monitoring hepatitis C virus infection among injecting drug
users in the European Union: a review of the literature.  Epi-
demiol Infect 2002, 129:577-585.
14. Hurley SF, Jolley DJ, Kaldor JM: Effectiveness of needle-exchange
programmes for prevention of HIV infection.  Lancet 1997,
21:1797-800.
15. Hagan H, Thiede H, Des Jarlais DC: HIV/hepatitis C virus coinfec-
tion in drug users: Risk behavior and prevention.  AIDS 2005,
19:S199-07.
16. Crofts N, Nigro L, Oman K, Stevenson E, Sherman J: Methadone
maintenance and hepatitis C virus infection among injecting
drug users.  Addiction 1997, 92:999-1005.
17. Thiede H, Hagan H, Murrill SM: Methadone treatment HIV and
hepatitis B and C risk reduction among injectors in the Seat-
tle area.  J Urban Health 2000, 77:331-345.
18. Maher L, Jiong L, Jalaludin B, Chant K, Kaldor J: High hepatitis C
incidence in new injecting drug users: A policy failure?  Aust
NZ J Public Health 2007, 31:30-35.
19. Judd A, Hutchinson S, Wadd S, Hickman M, Taylor A, Jones S, Parry
JV, Cameron S, Rhodes T, Ahmed S, Bird S, Fox R, Renton A, Stimson
GV, Goldberg D: Prevalence of, and risk factors for, hepatitis
C virus infection among recent initiates to injecting in Lon-
don and Glasgow: cross sectional analysis.  J Viral Hepat 2005,
6:655-62.
20. Ma teu-Gelabert P, Tr eloar C, Calatayud V, Sa ndoval M, Zur iá n J,
Maher L, Rhodes T, Friedman S: How can hepatitis C be pre-
vented in the long term?  Int J Drug Policy 2007, 18:338-40.
21. Hagan H, Thiede H, Weiss N: Sharing of drug preparation equip-
ment as a risk factor for hepatitis C.  Am J Public Health 2001,
91:1-6.
22. Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, et al.:
Hepatitis C virus seroconversion among young injection
drug users: Relationships and risks.  J InfectDis 2002,
186:1558-64.
23. Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson
J, et al.: Risk of hepatitis C virus infection among young adult
injection drug users who share injection equipment.  Am Jour-
nal Epidemiol 2002, 155:645-53.
24. Taylor A, Goldberg D, Hutchinson S, Cameron S, Gore SM, McMe-
namin J, Green S, Pithie A, Fox R: Prevalence of hepatitis C virus
infection among injecting drug users in Glasgow 1990–1996:
are current harm reduction strategies working?  Journal of
Infection 2000, 40:176-183.
25. Champion JK, Taylor A, Hutchinson S, Cameron S, McMenamin J,
Mitchell A, Goldberg D: Incidence of Hepatitis C Virus Infection
and Associated Risk Factors among Scottish Prison Inmates:
A Cohort Study.  Am J Epidemiol 2004, 159:514-519.
26. Taylor A, Fleming A, Rutherford J, Goldberg D: Examining the Injecting
Practices of Injecting Drug Users in Scotland Scottish Executive Effective
Interventions Unit, Edinburgh; 2004. 
27. Hyams KC, Phillips IA, Tejada A, Wignall FS, Roberts CR, Escamilla J:
Three-year incidence study of retroviral and viral hepatitis
transmission in a Peruvian prostitute population.  J Acquir
Immune Defic Syndr 1993, 6:1353-7.
28. Belza MJ, Clavo P, Ballesteros J, Menéndez B, Castilla J, Sanz S, Jerez
N, Rodríguez C, Sánchez F, del Romero J: Social and work condi-
tions, risk behaviour and prevalence of sexually transmitted
diseases among female immigrant prostitutes in Madrid
(Spain).  Gac Sanit 2004, 18:177-83.
29. Camejo MI, Mata G, Diaz M: Prevalence of hepatitis B, hepatitis
C and syphilis in female sex workers in Venezuela.  Rev Saude
Publica 2003, 37:339-44.